These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 21370912)

  • 1. Metal-based inhibition of poly(ADP-ribose) polymerase--the guardian angel of DNA.
    Mendes F; Groessl M; Nazarov AA; Tsybin YO; Sava G; Santos I; Dyson PJ; Casini A
    J Med Chem; 2011 Apr; 54(7):2196-206. PubMed ID: 21370912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural recognition of DNA by poly(ADP-ribose)polymerase-like zinc finger families.
    Petrucco S; Percudani R
    FEBS J; 2008 Mar; 275(5):883-93. PubMed ID: 18215166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Domain C of human poly(ADP-ribose) polymerase-1 is important for enzyme activity and contains a novel zinc-ribbon motif.
    Tao Z; Gao P; Hoffman DW; Liu HW
    Biochemistry; 2008 May; 47(21):5804-13. PubMed ID: 18452307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zinc is an essential cofactor for recognition of the DNA binding domain of poly(ADP-ribose) polymerase by antibodies in autoimmune rheumatic and bowel diseases.
    Decker P; Briand JP; de Murcia G; Pero RW; Isenberg DA; Muller S
    Arthritis Rheum; 1998 May; 41(5):918-26. PubMed ID: 9588745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In silico identification of poly(ADP-ribose)polymerase-1 inhibitors and their chemosensitizing effects against cisplatin-resistant human gastric cancer cells.
    Le TV; Suh JH; Kim N; Park HJ
    Bioorg Med Chem Lett; 2013 May; 23(9):2642-6. PubMed ID: 23522835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An enzymatic assay for poly(ADP-ribose) polymerase-1 (PARP-1) via the chemical quantitation of NAD(+): application to the high-throughput screening of small molecules as potential inhibitors.
    Putt KS; Hergenrother PJ
    Anal Biochem; 2004 Mar; 326(1):78-86. PubMed ID: 14769338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poly(ADP-ribose) polymerase as a drug target for cardiovascular disease and cancer: an update.
    Horvath EM; Szabó C
    Drug News Perspect; 2007 Apr; 20(3):171-81. PubMed ID: 17520094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 4-[3-(4-cyclopropanecarbonylpiperazine-1-carbonyl)-4-fluorobenzyl]-2H-phthalazin-1-one: a novel bioavailable inhibitor of poly(ADP-ribose) polymerase-1.
    Menear KA; Adcock C; Boulter R; Cockcroft XL; Copsey L; Cranston A; Dillon KJ; Drzewiecki J; Garman S; Gomez S; Javaid H; Kerrigan F; Knights C; Lau A; Loh VM; Matthews IT; Moore S; O'Connor MJ; Smith GC; Martin NM
    J Med Chem; 2008 Oct; 51(20):6581-91. PubMed ID: 18800822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional interaction between human papillomavirus type 18 E2 and poly(ADP-ribose) polymerase 1.
    Lee D; Kim JW; Kim K; Joe CO; Schreiber V; Ménissier-De Murcia J; Choe J
    Oncogene; 2002 Aug; 21(38):5877-85. PubMed ID: 12185587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platinated benzonaphthyridone is a stronger inhibitor of poly(ADP-ribose) polymerase-1 and a more potent anticancer agent than is the parent inhibitor.
    Wang B; Qian H; Yiu SM; Sun J; Zhu G
    Eur J Med Chem; 2014 Jan; 71():366-73. PubMed ID: 24361480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bcl-2 prevents topoisomerase II inhibitor GL331-induced apoptosis is mediated by down-regulation of poly(ADP-ribose)polymerase activity.
    Kuo ML; Shen SC; Yang CH; Chuang SE; Cheng AL; Huang TS
    Oncogene; 1998 Oct; 17(17):2225-34. PubMed ID: 9811453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of quinazolinone and quinoxaline derivatives as potent and selective poly(ADP-ribose) polymerase-1/2 inhibitors.
    Iwashita A; Hattori K; Yamamoto H; Ishida J; Kido Y; Kamijo K; Murano K; Miyake H; Kinoshita T; Warizaya M; Ohkubo M; Matsuoka N; Mutoh S
    FEBS Lett; 2005 Feb; 579(6):1389-93. PubMed ID: 15733846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistance-modifying agents. 5. Synthesis and biological properties of quinazolinone inhibitors of the DNA repair enzyme poly(ADP-ribose) polymerase (PARP).
    Griffin RJ; Srinivasan S; Bowman K; Calvert AH; Curtin NJ; Newell DR; Pemberton LC; Golding BT
    J Med Chem; 1998 Dec; 41(26):5247-56. PubMed ID: 9857092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utilization of a synthetic peptide as a tool to study the interaction of heavy metals with the zinc finger domain of proteins critical for gene expression in the developing brain.
    Razmiafshari M; Zawia NH
    Toxicol Appl Pharmacol; 2000 Jul; 166(1):1-12. PubMed ID: 10873713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of the antiproliferative activity of anticancer drugs in hematopoietic tumor cell lines by the poly(ADP-ribose) polymerase inhibitor 6(5H)-phenanthridinone.
    Holl V; Coelho D; Weltin D; Hyun JW; Dufour P; Bischoff P
    Anticancer Res; 2000; 20(5A):3233-41. PubMed ID: 11062748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein-protein interaction of the human poly(ADP-ribosyl)transferase depends on the functional state of the enzyme.
    Griesenbeck J; Oei SL; Mayer-Kuckuk P; Ziegler M; Buchlow G; Schweiger M
    Biochemistry; 1997 Jun; 36(24):7297-304. PubMed ID: 9200678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current development of clinical inhibitors of poly(ADP-ribose) polymerase in oncology.
    Ratnam K; Low JA
    Clin Cancer Res; 2007 Mar; 13(5):1383-8. PubMed ID: 17332279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and structure-activity relationships of novel pyrrolocarbazole lactam analogs as potent and cell-permeable inhibitors of poly(ADP-ribose)polymerase-1 (PARP-1).
    Wells GJ; Bihovsky R; Hudkins RL; Ator MA; Husten J
    Bioorg Med Chem Lett; 2006 Mar; 16(5):1151-5. PubMed ID: 16359865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor activity of Ru(III) complexes carrying beta-diketonato ligands in vitro and in vivo.
    Arandjelovic SS; Bjelogrlic KS; Malesevic NN; Tesic LjZ; Radulovic SS
    J BUON; 2009; 14(2):271-9. PubMed ID: 19650178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of poly(ADP-ribose) polymerase in cancer.
    Plummer ER
    Curr Opin Pharmacol; 2006 Aug; 6(4):364-8. PubMed ID: 16753340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.